Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Overactive Bladder
Related studies linked through entity extraction aliases.
Programmable Timer in the Bladder Rehabilitation Treatment of OAB
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
- Status
- COMPLETED
- Phase
- PHASE2
Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE4
Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase
- Status
- COMPLETED
- Phase
- PHASE2
NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder
- Status
- TERMINATED
- Phase
- PHASE2
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE3
MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE4
A Research Study for Patients With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome
- Status
- COMPLETED
- Phase
- PHASE3